Machine learning to predict urine culture antibiotic sensitivities in the emergency department
Abstract
BACKGROUND: Urinary tract infections (UTIs) are among the most common bacterial infections diagnosed in the emergency department. Treatment of UTIs is largely empiric because urine culture results are not rapidly available.
OBJECTIVES: We examined whether machine learning could predict antibiotic sensitivities of the urine cultures by using only data available during the clinical encounter.
METHODS: We used extreme gradient boosting (XGBoost) to examine 62,963 emergency department patient encounters from January 1, 2017, through December 31, 2021. All encounters included a urinalysis and urine culture. We included 1303 variables in the full model and examined 21 antibiotics. An antibiotic was characterized as sensitive only if all bacteria in the culture were susceptible; if ≥ 1 bacteria was not susceptible, then it was characterized as intermediate or resistant.
RESULTS: We predicted urine cultures to be sensitive vs intermediate or resistant with area under the receiver operating curve (AUROC) values ranging from 70 % (for amikacin) to 90 % (for linezolid) (median, 82 %) when negative urine cultures were characterized as antibiotic susceptible. AUROCs were as follows: nitrofurantoin (84 %); trimethoprim + sulfamethoxazole (80 %); ciprofloxacin (85 %); levofloxacin (85 %); first-generation cephalosporins (84 %); and third-generation cephalosporins (80 %). When models excluded urine cultures with no bacterial growth, AUROCs ranged from 66 % (for ampicillin) to 87 % (for…
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.